ArticleFolia microbiologica2026
Green synthesis and antifungal evaluation of Moringa oleifera-mediated iron oxide nanoparticles against Rhizopus stolonifer infecting Coleus scutellarioides.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal diseases reduce the ornamental and medicinal value of Coleus scutellarioides, while reliance on synthetic fungicides raises concerns regarding resistance development and environmental safety. Green synthesis of iron oxide nanoparticles using plant extracts offers a potentially safer alternative for disease suppression. This study evaluated Moringa oleifera leaf extract as a reducing and stabilizing agent for the synthesis of iron oxide nanoparticles and assessed their antifungal activity against Rhizopus stolonifer under greenhouse conditions. Iron oxide nanoparticles were synthesized using aqueous M. oleifera leaf extract and characterized by UV-Vis spectroscopy, FTIR, XRD, and SEM. A greenhouse experiment was conducted using four treatments: control, 2 ppm, 4 ppm, and 7 ppm. Each treatment had three biological replicates. Disease severity and disease incidence were recorded 7 days after inoculation and analyzed by one-way ANOVA followed by Tukey's HSD test at p < 0.05. UV-Vis analysis showed a distinct absorption peak at 595 nm. FTIR confirmed Fe-O absorption in the 400-600 cm⁻¹ region, while XRD identified crystalline α-Fe₂O₃. SEM showed flake-like aggregated particle domains ranging from 175 to 247 nm. Disease severity declined from 73.33% in the control to 26.66% at 7 ppm, whereas disease incidence decreased from 56.25% to 26.31%. ANOVA showed significant treatment effects for disease severity (F = 34.27, p < 0.001) and disease incidence (F = 28.14, p < 0.001). Green-synthesized iron oxide particles derived from M. oleifera significantly reduced Rhizopus disease development in C. scutellarioides in a dose-dependent manner under short-term greenhouse conditions. Future studies should include validation with additional R. stolonifer isolates, culture-collection reference strains, mechanistic assays, longer evaluation periods, positive fungicide controls, and field validation before broader application is considered.
Indexed as
Identifiers
42429851What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.